Related Experiment Video
Updated: Sep 5, 2025
05:38
Generation and Expansion of Human Cardiomyocytes from Patient Peripheral Blood Mononuclear Cells
Published on: February 12, 2021
4.3K
Improved Generation of Human Induced Pluripotent Stem Cell-Derived Cardiac Pacemaker Cells Using Novel
Fabrice F Darche1,2, Nina D Ullrich2,3, Ziqiang Huang4
1Department of Cardiology, Angiology and Pneumology, Heidelberg University Hospital, 69120 Heidelberg, Germany.
International Journal of Molecular Sciences
|July 9, 2022
Summary
We developed new methods to generate cardiac pacemaker cells from human-induced pluripotent stem cells (hiPSC) without using animal cells. Protocol E demonstrated the highest efficiency in producing these vital cells for potential therapies.
Area of Science:
- Stem cell biology
- Cardiovascular research
- Regenerative medicine
Background:
- Current human-induced pluripotent stem cell (hiPSC) differentiation protocols yield limited cardiac pacemaker cells.
- Previous co-culture methods with mouse END2 cells posed xenogeneic risks.
- Need for safe, efficient protocols for generating pacemaker cells.
Purpose of the Study:
- To develop novel, animal-cell-free protocols for hiPSC differentiation into cardiac pacemaker cells.
- To maintain high differentiation efficiency comparable to existing methods.
- To eliminate xenogeneic risks associated with END2 cell co-culture.
Main Methods:
- Investigated four new protocols (B, C, D, E) for hiPSC differentiation.
- Protocols involved manipulation of Wnt signaling pathway components (retinoic acid, CHIR99021, SB431542).
- Compared novel protocols against a reference END2 cell-based protocol (A).
Main Results:
- Protocol E upregulated 12 out of 15 cardiac pacemaker-specific genes, surpassing the reference protocol A (11 genes).
- Protocols B, C, and D showed lower gene upregulation (9, 10, and 8 genes, respectively).
- Cells differentiated via Protocol E exhibited strong pacemaker marker expression and responsiveness to adrenergic/cholinergic stimulation.
Conclusions:
- Four novel, animal-cell-independent protocols for hiPSC-derived cardiac pacemaker cells were established.
- Protocol E proved most effective in generating cardiac pacemaker cells.
- These findings offer a safer and more efficient approach for potential therapeutic applications.
